BackgroundPatients with inflammatory bowel disease (IBD) carry a 2–4 fold higher risk of venous thromboembolism (VTE) than persons in the general population. Most VTE present as deep vein thrombosis (DVT) of the lower extremity or as pulmonary emboli (PE), but they can also occur in other locations, including mesenteric and cerebral sinus thrombosis. Such atypical VTE may evade detection until the development of serious complications.
展开▼
